strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD)

May 2013

New guidelines will try to strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD).

PPIs are still the mainstay for treating patients with GERD...even though they've been under fire for some possible drawbacks.

PPIs likely increase the risk of Clostridium difficile and other GI infections...and there are questions about a higher risk of pneumonia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Med Administration buzz about a new report called Choosing Wisely
Overactive Bladder Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder
Insomnia Silenor (SI-leh-nor) is a NEW formulation of doxepin for insomnia
Travel Medicine Patients often ask how they can stay healthy while travelling
Smoking whether electronic cigarettes or hookah pipes are safer than smoking cigarettes
Pediatrics how to treat anxiety in kids
Antithrombotics whether to stop antithrombotics for MINOR surgical procedures or endoscopy
Dermatology Picato (pih-KAY-toe) gel as a more convenient topical treatment for actinic keratosis
Cardiology Many more patients will now ask about the Mediterranean diet
Fungal Infections how to get rid of fungal nail infections
Gastroenterology strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD)